Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek®) for the treatment of allergic rhinitis. Expert Rev Clin Immunol. 2018 Oct 22;: Authors: Nelson HS Abstract INTRODUCTION: Allergic rhinitis (AR) is among the most common chronic conditions affecting both children and adults. It is the cause of significant morbidity from the symptoms and interference with sleep. It results in major impairment of performance both at school and at work. In the U.S. and certain parts of Europe, ragweed pollen is a major cause of seasonal AR. In 2014, the U.S. Food and Drug Administration (FDA) approved a sublingual ragweed tablet (MK-3641) for use in adults with ragweed induced AR. Areas covered: This paper will review the impact of ragweed-induced AR and available treatments includi...
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2PS8t77
Τετάρτη 24 Οκτωβρίου 2018
Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek ®) for the treatment of allergic rhinitis.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.